Abstract
A significant percentage of breast cancer victims will suffer from metastases indicating that new approaches to preventing breast cancer metastasis are thus needed. Dietary stearate (ST) and chemotherapy have been shown to reduce breast cancer metastasis. We tested the complementary use of dietary ST with a taxol-based chemotherapy which work through separate mechanisms to reduce breast cancer metastasis. We therefore carried out a prevention study in which diets were initiated prior to human MDA-MB-435 cancer cells being injected into the host and a treatment study in which diets were combined with paclitaxel (PTX). Using an orthotopic athymic nude mouse model and three diets [corn oil (CO) control diet, low fat (LF) or ST] the prevention study demonstrated that the ST diet decreased the incidence of lung metastasis by 50 % compared to both the LF and CO diets. The ST diet also reduced the number and size of metastatic lung nodules compared to the LF diet. Results of the treatment study indicated that both the CO and ST diets decreased the number of mice with lung metastasis compared to the LF diet. Both CO and ST also decreased the number of lung metastases per mouse compared to the LF diet however only the ST diet cohort was significant. Histomorphometric analysis of the lung tumor tissue indicated that the ST diet plus PTX decreased angiogenesis compared to the LF diet plus PTX. In conclusion these results support combining diet with chemotherapy in both treatment and prevention settings.
Similar content being viewed by others
Abbreviations
- LF:
-
Low fat diet
- CO:
-
Corn oil diet
- ST:
-
Stearate diet
References
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
Saloustros E, Mavroudis D, Georgoulias V (2008) Paclitaxel and docetaxel in the treatment of breast cancer. Expert Opin Pharmacother 9:2603–2616
Pienta K (2001) Preclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancer. Semin Oncol 28(4 Suppl 15):3–7
Bogenrieder T, Herlyn M (2003) Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22:6524–6536
Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics, 2001. CA Cancer J Clin 51:15–36
Chung CT, Carlson RW (2003) Goals and objectives in the management of metastatic breast cancer. Oncologist 8:514–520
Grundy SM (1994) Influence of stearic acid on cholesterol metabolism relative to other long-chain fatty acids. Am J Clin Nutr 60:986S–990S
Hunter JE, Zhang J, Kris-Etherton PM (2010) Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr 91:46–63
Tinsley IJ, Schmitz JA, Pierce DA (1981) Influence of dietary fatty acids on the incidence of mammary tumors in the C3H mouse. Cancer Res 41:1460–1465
Bennett AS (1984) Effect of dietary stearic acid on the genesis of spontaneous mammary adenocarcinomas in strain A/ST mice. Int J Cancer 34:529–533
Habib NA, Wood CB, Apostolov K, Barker W, Hershman MJ, Aslam M, Heinemann D, Fermor B, Williamson RC, Jenkins WE et al (1987) Stearic acid and carcinogenesis. Br J Cancer 56:455–458
Singh RK, Hardy RW, Wang MH, Williford J, Gladson CL, McDonald JM, Siegal GP (1995) Stearate inhibits human tumor cell invasion. Invasion Metastasis 15:144–155
Wickramasinghe NS, Jo H, McDonald JM, Hardy RW (1996) Stearate inhibition of breast cancer cell proliferation. A mechanism involving epidermal growth factor receptor and G-proteins. Am J Pathol 148:987–995
Hardy S, El-Assaad W, Przybytkowski E, Joly E, Prentki M, Langelier Y (2003) Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin. J Biol Chem 278:31861–31870
Evans LM, Cowey SL, Siegal GP, Hardy RW (2009) Stearate preferentially induces apoptosis in human breast cancer cells. Nutr Cancer 61:746–753
Evans LM, Toline EC, Desmond R, Siegal GP, Hashim AI, Hardy RW (2009) Dietary stearate reduces human breast cancer metastasis burden in athymic nude mice. Clin Exp Metastasis 26:415–424
Li C, Zhao X, Toline E, Siegal GP, Evans LM, Ibrahim-Hashim A, Desmond R, Hardy RW (2011) Prevention of carcinogenesis and inhibition of breast cancer tumor burden by dietary stearate. Carcinogenesis 32:1251–1258
Townson JL, Naumov GN, Chambers AF (2003) The role of apoptosis in tumor progression and metastasis. Curr Mol Med 3:631–642
Boedefeld WM II, Bland KI, Heslin MJ (2003) Recent insights into angiogenesis, apoptosis, invasion, and metastasis in colorectal carcinoma. Ann Surg Oncol 10:839–851
Weidner N (1995) Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 36:169–180
Ingber DE (2008) Can cancer be reversed by engineering the tumor micro-environment? Semin Cancer Biol 18:356–364
Schmitz AA, Govek EE, Böttner B, Van Aelst L (2000) Rho GTPases: signaling, migration, and invasion. Exp Cell Res 25:1–12
Merajver SD, Usmani SZ (2005) Multifaceted role of Rho proteins in angiogenesis. J Mammary Gland Biol Neoplasia 10:291–298
Pillé JY, Denoyelle C, Varet J et al (2005) Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol Ther 11:267–274
Welsch CW (1992) Dietary fat, calories, and mammary gland tumorigenesis. Adv Exp Med Biol 322:203–222
Rose DP, Connolly JM (1992) Influence of dietary fat intake on local recurrence and progression of metastases arising from MDA-MB-435 human breast cancer cells in nude mice after excision of the primary tumor. Nutr Cancer 18:113–122
Warburg O, Wind F, Negelein E (1927) The metabolism of tumors in the body. J Gen Physiol 8:519–530
Klement RJ, Kammerer U (2011) Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab 8:75
Saadatian-Elahi M, Norat T, Goudable J, Riboli E (2004) Biomarkers of dietary fatty acid intake and the risk of breast cancer: a meta-analysis. Int J Cancer 111:584–591
Munaron L (2006) Intracellular calcium, endothelial cells and angiogenesis. Recent Pat Anticancer Drug Discov 1:105–119
Naumova E, Ubezio P, Garofalo A et al (2006) The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis. Clin Cancer Res 12:1839–1849
Dong LF, Swettenham E, Eliasson J et al (2007) Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: the role of oxidative stress. Cancer Res 67:11906–11913
Artwohl M, Roden M, Waldhäusl W et al (2004) Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells. FASEB J 18:146–158
Artwohl M, Lindenmair A, Sexl V et al (2008) Different mechanisms of saturated versus polyunsaturated FFA-induced apoptosis in human endothelial cells. J Lipid Res 49:2627–2640
Chambers AF (2009) MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? Cancer Res 69:5292–5293
Nerlich AG, Bachmeier BE (2013) Density-dependent lineage instability of MDA-MB-435 breast cancer cells. Oncol Lett 5:1370–1374
Rae JM, Creighton CJ, Meck JM et al (2007) MDA-MB-435 cells are derived from M14 melanoma cells: a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res Treat 104:13–19
Christgen M, Lehmann U (2007) MDA-MB-435: the questionable use of a melanoma cell line as a model for human breast cancer is ongoing. Cancer Biol Ther 6:1355–1357
Acknowledgments
This study was funded by the UAB SPORE in Breast Cancer 5P50CA089019. We express our appreciation to the UAB Metabolic Bone Disease Histomorphometry Core Laboratory for processing the formalin-fixed paraffin-embedded sections, and carrying out the immunostaining and histomorphometry.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zhao, X., Rezonzew, G., Wang, D. et al. Diet modulation is an effective complementary agent in preventing and treating breast cancer lung metastasis. Clin Exp Metastasis 31, 625–638 (2014). https://doi.org/10.1007/s10585-014-9654-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10585-014-9654-5